IC-VL (n = 84) | HIV-VL (n = 11) | IS-VL (n = 16) | Total VL (n = 111) | P-value | |
---|---|---|---|---|---|
Male (%) | 73 | 82 | 56 | 71 | 0.297 |
Age (mean ± SD, years) | 44.0 ± 16.5 | 38.2 ± 8.0 | 54.8 ± 16.0 | 45.0 ± 16.9 | ANOVA: F(2, 110) = 6.22, P = 0.017* |
Immigrants (%) | 58 | 73 | 13 | 53 | χ2 = 13.22, df = 2, P = 0.001* |
Sub-Saharan origin (%) | 54 | 36 | 13 | 46 | χ2 = 9.58, df = 2, P = 0.008* |
Diabetes (%) | 16 | 9 | 13 | 14 | 0.828 |
Distance to park (mean ± SD, m) | 922 ± 566 | 928 ± 701 | 917 ± 544 | 921 ± 569 | 0.999 |
Delay of diagnosisa (median (IQR), days) | 18.5 (14–30) | 21 (16–60) | 24 (10–60) | 20 (13–30) | 0.640 |
Fever (%) | 98 | 73 | 94 | 95 | χ2 = 11.81, df = 2, P = 0.003* |
Asthenia (%) | 49 | 46 | 69 | 51 | 0.315 |
Weight loss (%) | 40 | 36 | 31 | 39 | 0.786 |
Anorexia (%) | 33 | 36 | 25 | 32 | 0.784 |
Cough (%) | 31 | 36 | 31 | 32 | 0.836 |
Cephalea (%) | 35 | 9 | 19 | 30 | 0.113 |
Vomiting (%) | 21 | 9 | 0 | 16 | 0.056 |
Abdominal pain (%) | 15 | 18 | 12 | 15 | 0.762 |
Odynophagia (%) | 10 | 9 | 6 | 9 | 0.906 |
Diarrhoea (%) | 6 | 18 | 13 | 8 | 0.314 |
Dyspnoea (%) | 7 | 9 | 0 | 6 | 0.512 |
Weight (mean ± SD, kg) | 78.5 ± 19.1 | 68.3 ± 18.0 | 76.4 ± 20.1 | 77.1 ± 19.2 | 0.254 |
Clinical splenomegaly (%) | 29 | 46 | 31 | 31 | 0.537 |
Radiological splenomegaly, n/T (%) | 75/79 (95) | 10/11 (91) | 13/15 (87) | 93 | 0.472 |
Spleen size (mean ± SD, cm) | 15.7 ± 2.0 | 15.9 ± 2.1 | 15.2 ± 2.32 | 15.7 ± 2.0 | 0.627 |
Anaemia (haemoglobin < 12 mg/dl) (%) | 87 | 82 | 94 | 87 | 0.599 |
Haemoglobin (mean ± SD, mg/dl) | 10.2 ± 1.7 | 10.9 ± 1.3 | 9.4 ± 1.5 | 10.2 ± 1.7 | ANOVA: F(2, 106) = 3.24, P = 0.043* |
Leukopenia (< 4000/mm3) (%) | 90 | 82 | 94 | 90 | 0.587 |
Leucocytes (mean ± SD, mm3) | 2715 ± 902 | 2513 ± 1208 | 2470 ± 1083 | 2658 ± 958 | 0.565 |
Thrombocytopenia (< 150,000/mm3) (%) | 93 | 91 | 100 | 94 | 0.512 |
Platelets (mean ± SD, mm3) | 93,379 ± 41,771 | 103,364 ± 38,263 | 77,875 ± 29,132 | 92,111 ± 40,077 | 0.228 |
CRP (mean ± SD, mg/dl) | 12.2 ± 7.3 | 8.3 ± 6.8 | 9.2± 6.9 | 11.3 ± 7.3 | 0.112 |
CRP > 10 mg/dl | 56 | 36 | 38 | 51 | 0.225 |
Ferritin (median (IQR), ng/ml) | 2264 (914–6368.5) | 712 (469–1098.5) | 1854 (1146–5369) | 1969 (838–5784) | Kruskal-Wallis H-test: χ2 = 6.31, df = 2, P = 0.043* |
Ferritin > 1000 ng/ml, n/T (%) | 56/73 (77) | 1/6 (17) | 11/14 (79) | 68/93 (73) | χ2 = 11.81, df = 2, P = 0.005* |
ESR, n/T (mean ± SD, mm/h) | 25/44 (73 ± 32) | 3/6 (73 ± 26) | 2/11 (60 ± 35) | 30/61 (71 ±32) | 0.494 |
ESR > 70 mm/h, n/T (%) | 25/44 (57) | 3/6 (50) | 2/11 (18) | 30/61 (49) | 0.072 |
Triglycerides (mean ± SD, mg/dl) | 220 ± 81 | 170 ± 66 | 203 ± 64 | 211 ± 78 | 0.124 |
HLHb, n (%) | 31 (37) | 2 (18) | 9 (56) | 42 (38) | 0.129 |
Auto-antibody positive, n/T (%) | 13/44 (30) | 2/4 (50) | 3/14 (21) | 18/62 (29) | 0.535 |
Serology infectious diseasesc positives, n/T (%) | 25/55 (46) | 1/6 (17) | 5/10 (50) | 31/71 (44) | 0.366 |